Nu Skin stock falls after outlook cut on China sales
Nu Skin Enterprises Inc. (NUS) shares fell in the extended session Tuesday after the beauty and wellness products maker cut its outlook. Nu Skin shares fell 14% after hours, following a 3.4% rise to close the regular session at $45.51. The company forecast earnings of 82 cents to 84 cents a share on revenue of $622 million to $623 million for the second quarter, and $3.20 to $3.25 a share on revenue of $2.48 billion to $2.52 billion for the year. Analysts surveyed by FactSet had estimated earnings of 93 cents a share on revenue of $672.5 million for the second quarter, and $3.94 a share on revenue of $2.77 billion for the year. "We are adjusting our guidance for the year primarily due to a reduced revenue outlook in Mainland China following the government's 100-day campaign to review and inspect the health products and direct selling industries," said Nu Skin Chief Executive Ritch Wood in a statement. "Continued restrictions on sales meetings, as well as media scrutiny, have negatively impacted consumer sentiment and contributed to this adjustment."
-Wallace Witkowski; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
July 16, 2019 17:17 ET (21:17 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.